These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20010364)

  • 1. Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease.
    Hodgkinson K; Dicks E; Connors S; Young TL; Parfrey P; Pullman D
    Genet Med; 2009 Dec; 11(12):859-65. PubMed ID: 20010364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from arrhythmogenic right ventricular cardiomyopathy research.
    Taylor M
    Genet Med; 2009 Dec; 11(12):850-1. PubMed ID: 20010363
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).
    Hodgkinson KA; Parfrey PS; Bassett AS; Kupprion C; Drenckhahn J; Norman MW; Thierfelder L; Stuckless SN; Dicks EL; McKenna WJ; Connors SP
    J Am Coll Cardiol; 2005 Feb; 45(3):400-8. PubMed ID: 15680719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.
    Haywood AF; Merner ND; Hodgkinson KA; Houston J; Syrris P; Booth V; Connors S; Pantazis A; Quarta G; Elliott P; McKenna W; Young TL
    Eur Heart J; 2013 Apr; 34(13):1002-11. PubMed ID: 23161701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
    Merner ND; Hodgkinson KA; Haywood AF; Connors S; French VM; Drenckhahn JD; Kupprion C; Ramadanova K; Thierfelder L; McKenna W; Gallagher B; Morris-Larkin L; Bassett AS; Parfrey PS; Young TL
    Am J Hum Genet; 2008 Apr; 82(4):809-21. PubMed ID: 18313022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.
    Milting H; Klauke B; Christensen AH; Müsebeck J; Walhorn V; Grannemann S; Münnich T; Šarić T; Rasmussen TB; Jensen HK; Mogensen J; Baecker C; Romaker E; Laser KT; zu Knyphausen E; Kassner A; Gummert J; Judge DP; Connors S; Hodgkinson K; Young TL; van der Zwaag PA; van Tintelen JP; Anselmetti D
    Eur Heart J; 2015 Apr; 36(14):872-81. PubMed ID: 24598986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations.
    Baskin B; Skinner JR; Sanatani S; Terespolsky D; Krahn AD; Ray PN; Scherer SW; Hamilton RM
    Hum Genet; 2013 Nov; 132(11):1245-52. PubMed ID: 23812740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.
    Dominguez F; Zorio E; Jimenez-Jaimez J; Salguero-Bodes R; Zwart R; Gonzalez-Lopez E; Molina P; Bermúdez-Jiménez F; Delgado JF; Braza-Boïls A; Bornstein B; Toquero J; Segovia J; Van Tintelen JP; Lara-Pezzi E; Garcia-Pavia P
    Heart Rhythm; 2020 Jun; 17(6):945-954. PubMed ID: 32062046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
    Bhonsale A; James CA; Tichnell C; Murray B; Madhavan S; Philips B; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):569-78. PubMed ID: 23671136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice.
    Pullman D; Hodgkinson K
    Clin Genet; 2006 Mar; 69(3):199-203. PubMed ID: 16542381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
    Groeneweg JA; Bhonsale A; James CA; te Riele AS; Dooijes D; Tichnell C; Murray B; Wiesfeld AC; Sawant AC; Kassamali B; Atsma DE; Volders PG; de Groot NM; de Boer K; Zimmerman SL; Kamel IR; van der Heijden JF; Russell SD; Jan Cramer M; Tedford RJ; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Hauer RN; Calkins H
    Circ Cardiovasc Genet; 2015 Jun; 8(3):437-46. PubMed ID: 25820315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Thiene G; Corrado D; Basso C
    Orphanet J Rare Dis; 2007 Nov; 2():45. PubMed ID: 18001465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43.
    Hodgkinson KA; Connors SP; Merner N; Haywood A; Young TL; McKenna WJ; Gallagher B; Curtis F; Bassett AS; Parfrey PS
    Clin Genet; 2013 Apr; 83(4):321-31. PubMed ID: 22725725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():24-31. PubMed ID: 20089484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic Right Ventricular Cardiomyopathy: Progress Toward Personalized Management.
    James CA; Calkins H
    Annu Rev Med; 2019 Jan; 70():1-18. PubMed ID: 30355260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy and arrhythmogenic right ventricular dysplasia in young patients.
    Frias PA
    Semin Pediatr Neurol; 2005 Mar; 12(1):25-31. PubMed ID: 15929462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arrhythmogenic right ventricular dysplasia/cardiomyopathy - diagnosis in childhood].
    Kriebel T; Korte T; Kandolf R; Jux C; Windhagen-Mahnert B; Bökenkamp R; Bertram H; Paul T
    Z Kardiol; 2003 May; 92(5):418-24. PubMed ID: 12966835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.